Cyclins and CDKs are essential for the orderly progression of the cell cycle. In cancer, overexpression of cyclins (e.g., Cyclin D1) or mutations that lead to the constitutive activation of CDKs can drive the cell cycle forward unchecked. This abnormal activity can bypass cell cycle checkpoints, allowing cells with genetic abnormalities to divide and proliferate.
